1 Result

People

  1. Chung
    Chung
  2. Devlin
    Devlin
  3. Giralt
    Giralt
  4. Hassoun
    Hassoun
  5. Hilden
    Hilden
  6. Koehne
    Koehne
  7. Landau
    Landau
  8. Lendvai
    Lendvai
  9. Lesokhin
    Lesokhin
  10. Redling
    Redling

Groups

  1. Biostatistics Service (1)
  2. Bone Marrow Transplant (1)
  3. Cardiology (1)
  4. Center for Hematologic Malignancies (1)
  5. Department of Medicine (1)
  6. Division of Subspecialty Medicine (1)
  7. Epidemiology and Biostatistics (1)
  8. Hematologic Malignancies Research (1)
  9. Hematologic Malignancies, Division of (1)
  10. Myeloma (1)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Hani Hassoun"
  4. "2014"
  5. "Journal article"
Formats
  1. Journal Article (1)
Groups
  1. Biostatistics Service (1)
  2. Bone Marrow Transplant (1)
  3. Cardiology (1)
  4. Center for Hematologic Malignancies (1)
  5. Department of Medicine (1)
  6. Division of Subspecialty Medicine (1)

More Groups

People
  1. Alexander Lesokhin (1)
  2. David Chung (1)
  3. Guenther Koehne (1)
  4. Hani Hassoun (1)
  5. Heather Landau (1)
  6. Ioanna Tsakos (1)

More People

Years
  1. 2014 (1)
Publications
  1. Blood (1)
Publishers
  1. American Society of Hematology (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma
    Journal Article

    Lendvai, N.; Hilden, P.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Tsakos, I.; Redling, K.; Koehne, G.; Chung, D. J.; more...
    Blood (2014)

    Fulltext@MSK | Save